Experts Warn Against Relaxing Drug Approval Process
Citing the University of Sydney, and the Journal Nature, ScienceDaily reports that, “The warning follows a speech to Congress last week by President Trump in which he said the US Food and Drug Administration’s drug approval process was ‘too slow and burdensome,’ and where he promised to ‘slash the restraints, not just at FDA but…